Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by GLN1 belongs to the glutamine synthetase family. Additionally we are shipping Glutamine Synthetase Proteins (21) and Glutamine Synthetase Kits (9) and many more products for this protein.
Showing 10 out of 63 products:
Human Monoclonal GLN1 Primary Antibody for BI, IF - ABIN968014
Fei, DAmbrosio, Li, Surmacz, Baserga: Association of insulin receptor substrate 1 with simian virus 40 large T antigen. in Molecular and cellular biology 1995
Show all 5 references for ABIN968014
Arabidopsis thaliana Polyclonal GLN1 Primary Antibody for WB - ABIN2559393
Brouwer, Ziolkowska, Bagard, Keech, Gardeström: The impact of light intensity on shade-induced leaf senescence. in Plant, cell & environment 2012
Show all 3 references for ABIN2559393
Human Polyclonal GLN1 Primary Antibody for EIA, WB - ABIN453059
Di Tommaso, Destro, Seok, Balladore, Terracciano, Sangiovanni, Iavarone, Colombo, Jang, Yu, Jin, Morenghi, Park, Roncalli: The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. in Journal of hepatology 2009
Cow (Bovine) Polyclonal GLN1 Primary Antibody for IHC, WB - ABIN188921
Chakravarthy, Beli, Navitskaya, OReilly, Wang, Kady, Huang, Grant, Busik: Imbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy. in PLoS ONE 2016
This study demonstrated that Influence of glutamine synthetase (show GLUL Antibodies) gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
GS is acetylated at lysines 11 and 14, yielding a degron that is necessary and sufficient for binding and ubiquitylation by CRL4(CRBN (show CRBN Antibodies)) and degradation by the proteasome.
Studied molecular mechanisms of glutamine synthetase (show GLUL Antibodies) mutations that lead to clinically relevant pathologies.
GLUL (show GLUL Antibodies) rs10911021 is associated prospectively with adjudicated cardiovascular composite end points among overweight/obese individuals with type 2 diabetes.
Data show that glutamine synthetase (GS (show GLUL Antibodies)) produces glutamine (show GFPT1 Antibodies) (Gln) from tricarboxylic acid (TCA)-cycle-derived carbons.
Data indicate that the triple stain of reticulin, glypican-3 (show GPC3 Antibodies), and glutamine (show GFPT1 Antibodies) synthetae is useful in the differentiation of hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia.
Results highlight the diagnostic errors that can be caused by variant patterns of staining with glutamine synthetase (show GLUL Antibodies) and serum amyloid-associated protein in inflammatory hepatocellular adenoma and focal nodular hyperplasia.
High Glutamine synthetase (show GLUL Antibodies) expression is associated with epilepsy in newly diagnosed glioblastoma multiforme.
Glutamine synthetase (show GLUL Antibodies) expression is increased in regenerating hepatocytes and in early hepatocyte progenitor cells prior to morphological evidence of hepatocellular differentiation.
through a 3-stage genome-wide association study in 4188 type 2 diabetic patients, identified a novel susceptibility locus for coronary heart disease in the region of the GLUL (show GLUL Antibodies) gene
This study concludes that hepatic expression of alanine transaminase and glutathione synthetase (GS (show GSS Antibodies)) are reduced in aged cows, and administration of 17beta-estradiol increases plasma estradiol and hepatic GS.
Data show that glutamine synthetase (GS (show GLUL Antibodies))protein was preferentially expressed in hepatocytes adjacent to oxygen-supplying capillaries and in previously CPS-positive hepatocytes.
Diabetes induces TXNIP (show TXNIP Antibodies) expressions at mRNA levels, but shows the opposite effect on GS.
Results indicate that astrocyte glutamine synthase may be the predominant contributor to the pathogenic mechanisms of D-gal (show GAL Antibodies)-induced brain aging in mice.
Hepatic deletion of GS triggered systemic hyperammonemia, which was associated with cerebral oxidative stress as indicated by increased levels of oxidized RNA and enhanced protein Tyr (show TYR Antibodies) nitration.
modulation of intracellular glutamine (show GFPT1 Antibodies) levels by GS expression represents an endogenous mechanism through which mature adipocytes control the inflammatory response
GABABR2 (show GABBR2 Antibodies) has a role as a regulator of glutamine synthetase (show GLUL Antibodies) stability
the capacity for ammonia disposal correlated inversely with the expression of glutamine synthetase (show GLUL Antibodies) in muscle
Glutamine synthetase (show GLUL Antibodies) in astrocytes from entorhinal cortex of the triple transgenic animal model of Alzheimer's disease is not affected by pathological disease progression.
Renal glutamine synthetase (show GLUL Antibodies) is expressed in type A intercalated cells, non-A, non-B intercalated cells, and distal convoluted tubule cells, but not in principal cells, type B intercalated cells, or connecting segment cells.
Methionine sulfoximine target glutamine synthetase (show GLUL Antibodies) is required for the early steps of the cytokine response to endotoxins, and that its pharmacological inhibition may be exploited to treat inflammation.
BDNF (show BDNF Antibodies) can up-regulate GLAST (show SLC1A3 Antibodies) and GS and increase glutamate (show GRIN1 Antibodies) uptake during hypoxia, and these functions may underlie its neuroprotective effects.
The protein encoded by this gene belongs to the glutamine synthetase family. It catalyzes the synthesis of glutamine from glutamate and ammonia. Glutamine is a main source of energy and is involved in cell proliferation, inhibition of apoptosis, and cell signaling. This gene is expressed during early fetal stages, and plays an important role in controlling body pH by removing ammonia from circulation. Mutations in this gene are associated with congenital glutamine deficiency. Several alternatively spliced transcript variants have been found for this gene.
cell proliferation-inducing protein 59
, glutamate decarboxylase
, glutamate--ammonia ligase
, glutamine synthase
, glutamine synthetase
, proliferation-inducing protein 43
, glutamate-ammonia ligase (glutamine synthase)
, glutamate-ammonia ligase (glutamine synthetase)
, Glutamine synthetase (glutamate-ammonia ligase)
, glutamine synthetase 1